127 related articles for article (PubMed ID: 16333815)
21. Should TPMT genotype and activity be used to monitor 6-mercaptopurine treatment in children with acute lymphoblastic leukaemia?
Fakhoury M; Andreu-Gallien J; Mahr A; Medard Y; Azougagh S; Vilmer E; Jacqz-Aigrain E
J Clin Pharm Ther; 2007 Dec; 32(6):633-9. PubMed ID: 18021342
[TBL] [Abstract][Full Text] [Related]
22. [Levels of intracellular IL-6 and IFN-gamma in children with acute lymphoblastic leukemia].
Yin HQ; Qiao ZH; Zhu L; Zhang L; Su LP; Lu YJ
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Dec; 8(6):461-3. PubMed ID: 17178034
[TBL] [Abstract][Full Text] [Related]
23. Insulin and oleate promote translocation of inosine-5' monophosphate dehydrogenase to lipid bodies.
Whitehead JP; Simpson F; Hill MM; Thomas EC; Connolly LM; Collart F; Simpson RJ; James DE
Traffic; 2004 Oct; 5(10):739-49. PubMed ID: 15355510
[TBL] [Abstract][Full Text] [Related]
24. Comparative analysis of differential expression of sialic acids and adhesion molecules on mononuclear cells of bone marrow and peripheral blood in childhood acute lymphoblastic leukaemia at diagnosis and clinical remission.
Chowdhury S; Bandyopadhyay S; Chandra S; Mandal C
Indian J Biochem Biophys; 2007 Oct; 44(5):357-65. PubMed ID: 18341211
[TBL] [Abstract][Full Text] [Related]
25. Regulation of O-acetylation of sialic acids by sialate-O-acetyltransferase and sialate-O-acetylesterase activities in childhood acute lymphoblastic leukemia.
Mandal C; Mandal C; Chandra S; Schauer R; Mandal C
Glycobiology; 2012 Jan; 22(1):70-83. PubMed ID: 21803834
[TBL] [Abstract][Full Text] [Related]
26. Determination of inosine 5'-monophosphate dehydrogenase activity in red blood cells of thiopurine-treated patients using HPLC.
Beringer A; Citterio-Quentin A; Otero RO; Gustin C; Clarke R; Salvi JP; Boulieu R
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Feb; 1044-1045():194-199. PubMed ID: 28110955
[TBL] [Abstract][Full Text] [Related]
27. A study of the relationship between expression level of TRF1 protein and telomerase activity in human acute leukemia.
Shi JM; Huang H; Chen QF; Lin MF
J Zhejiang Univ Sci B; 2006 Feb; 7(2):154-8. PubMed ID: 16421973
[TBL] [Abstract][Full Text] [Related]
28. Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15.
Manabe A; Ohara A; Hasegawa D; Koh K; Saito T; Kiyokawa N; Kikuchi A; Takahashi H; Ikuta K; Hayashi Y; Hanada R; Tsuchida M;
Haematologica; 2008 Aug; 93(8):1155-60. PubMed ID: 18519521
[TBL] [Abstract][Full Text] [Related]
29. Level of tau protein in children treated for acute lymphoblastic leukemia.
Muszyńska-Rosłan K; Krawczuk-Rybak M; Protas PT; Hołownia A
Pediatr Neurol; 2006 May; 34(5):367-71. PubMed ID: 16647996
[TBL] [Abstract][Full Text] [Related]
30. The conformation of NADH bound to inosine 5'-monophosphate dehydrogenase determined by transferred nuclear Overhauser effect spectroscopy.
Schalk-Hihi C; Zhang YZ; Markham GD
Biochemistry; 1998 May; 37(20):7608-16. PubMed ID: 9585576
[TBL] [Abstract][Full Text] [Related]
31. Prognostic factors for leukemic induction failure in children with acute lymphoblastic leukemia and outcome after salvage therapy: the FRALLE 93 study.
Oudot C; Auclerc MF; Levy V; Porcher R; Piguet C; Perel Y; Gandemer V; Debre M; Vermylen C; Pautard B; Berger C; Schmitt C; Leblanc T; Cayuela JM; Socie G; Michel G; Leverger G; Baruchel A
J Clin Oncol; 2008 Mar; 26(9):1496-503. PubMed ID: 18349402
[TBL] [Abstract][Full Text] [Related]
32. [Comparative study on clinical features between TEL-AML1 positive and negative childhood acute lymphoblastic leukemia].
Guo X; Li Q; Zhu YP; Zhou CY; Gao J; Li XH; Pan LL; Li FY; Tian X; Liu HT
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Oct; 24(5):560-3. PubMed ID: 17922427
[TBL] [Abstract][Full Text] [Related]
33. Effects of the IMP-dehydrogenase inhibitor, Tiazofurin, in bcr-abl positive acute myelogenous leukemia. Part II. In vitro studies.
Wright DG; Boosalis M; Malek K; Waraska K
Leuk Res; 2004 Nov; 28(11):1137-43. PubMed ID: 15380336
[TBL] [Abstract][Full Text] [Related]
34. Quantitation of Human herpes virus 6 genome in children with acute lymphoblastic leukemia.
Seror E; Coquerel B; Gautheret-Dejean A; Ballerini P; Landman-Parker J; Leverger G; Schneider P; Vannier JP
J Med Virol; 2008 Apr; 80(4):689-93. PubMed ID: 18297709
[TBL] [Abstract][Full Text] [Related]
35. [Plasma concentrations of vascular endothelial growth factor and tissue factor in children with acute lymphoblastic leukemia].
Yang HQ; Zhang RH; Zhang ZH; Wan CC; Xia YJ
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Dec; 9(6):526-8. PubMed ID: 18082030
[TBL] [Abstract][Full Text] [Related]
36. Good early treatment response in childhood acute lymphoblastic leukemia is associated with Bax nuclear accumulation and PARP cleavage.
Urasiński T; Urasińska E; Grabarek J; Fydryk J; Domagała W
Med Sci Monit; 2009 Jun; 15(6):CR294-301. PubMed ID: 19478700
[TBL] [Abstract][Full Text] [Related]
37. Inosine 5'-monophosphate dehydrogenase inhibitors for the treatment of autoimmune diseases.
Ratcliffe AJ
Curr Opin Drug Discov Devel; 2006 Sep; 9(5):595-605. PubMed ID: 17002220
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of high-dose methotrexate in infants treated for acute lymphoblastic leukemia.
Lönnerholm G; Valsecchi MG; De Lorenzo P; Schrappe M; Hovi L; Campbell M; Mann G; Janka-Schaub G; Li CK; Stary J; Hann I; Pieters R;
Pediatr Blood Cancer; 2009 May; 52(5):596-601. PubMed ID: 19132729
[TBL] [Abstract][Full Text] [Related]
39. Features at presentation predict children with acute lymphoblastic leukemia at low risk for tumor lysis syndrome.
Truong TH; Beyene J; Hitzler J; Abla O; Maloney AM; Weitzman S; Sung L
Cancer; 2007 Oct; 110(8):1832-9. PubMed ID: 17724682
[TBL] [Abstract][Full Text] [Related]
40. Inosine monophosphate dehydrogenase (IMPDH) as a target in drug discovery.
Shu Q; Nair V
Med Res Rev; 2008 Mar; 28(2):219-32. PubMed ID: 17480004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
